With two approved therapeutics and the field working to develop the next generation of IPF drugs, the opportunity to become the undisputed, most effective, and disease-modifying agent on the market has never been greater. From repairing and regenerating lung tissue to illuminating innovative clinical trial design and advance scientific progress; the 6th IPF Summit is your one-stop-shop to supercharge IPF research and drug development. […]

Over the last 12 months, the industry has witnessed promising data and candidates entering the clinic. 7 Hills Pharma, Corbus Pharmaceuticals, Vincerx, and Morphic are paving the way to develop a safe, efficacious integrins-targeted drug to modify disease biology, which will be a game-changer for diseases such as oncology, autoimmune, and ophthalmology, with unmet medical needs. In collaboration with leading integrin drug developers, […]

Hundreds of clinical trials using AAV are underway, with several hundred more in preclinical development. Given the sheer volume of studies in the pipeline, the need to administer high doses, the clinical holds placed on gene therapy trials, and regulatory bodies being increasingly stringent on the safety standards they require; it has never been more […]

Over the last half-decade, we have witnessed game-changing developments within the cannabinoid field, driving it into a new era of rigorous research, promising clinical trials and multimillion-dollar deals. Right now, there are 50 cannabinoid therapeutic trials taking place at phases 2 and 3, pushing for approval to meet the clinical needs of patients with chronic […]

Revolutionizing Genetic Therapy Development & Delivery to the Eye Discovering Next Generation Administration Routes for the Eye; Overcoming the Translational Challenges of Ophthalmic Preclinical Models; & Discussing Toxicity & Targeting Challenges of Vector-Based Approaches The ophthalmology field is bursting with novel genetic approaches for targeting many disorders, with gene therapy taking centre stage as a […]

Translating Scientific Methodologies Addressing the Skin Microbiome into Commercially Viable Dermatological Therapeutics & Cosmetic Products Skin microbiome research is continuing to gain increasing market traction from a number of stakeholders, including drug developers and cosmetic brands. For investment and progress to continue, it is vital to meet and connect with the key opinion leaders in […]

Back to Boston with a bang! With 1,500 CAR and TCR developers, 200 speakers, 150 live presentations, 20 hours of networking and more surprises in store, the 7th CAR-TCR Summit will be the BIGGEST ever. Gain end-to-end insights from industry giants and the innovators bringing disruptive technologies from bench to bedside and from vein to vein. Discuss […]

2nd Annual Aseptic Processing Conference  Conference: 19 – 20 September 2022 Workshop: 21 September 2022 London, UK http://www.asepticprocessing.co.uk/PJWL Sponsored by: Dec Group, Rapid Micro Biosystems, Raumedic and STERIS Conference Chairman: James Drinkwater, Head of Aseptic Processing Special Interest Group PHSS and Head of GMP Compliance, F Ziel GMBH Driving a Holistic Approach to Assurance of Product Sterility through Aseptic […]

SAE Media Group’s 3rd Annual Conference September 19 - 20, 2022 | San Francisco, CA, USA ------------------------------------------------------------------------- The pre-filled syringes industry is growing at an exponential rate with innovations in parenteral delivery device development to aid self-administration and deliver biologics, high concentration, and large-volume drug products. This year’s conference will be assessing the latest developments […]

Advances in molecular and immunohistochemical techniques have ushered the NSCLC space into an exciting era of personalized medicine and improved outcomes – and a plethora of novel therapies are now in clinical development. Despite this, and whether patients fit into one of the actionable alteration subtypes of NSCLC or not, most will progress and/or develop […]

The mRNA Process Development & Manufacturing Summit will be taking place in-person in Boston, MA this month (September 20 – 22, 2022). The only conference roadmap to accelerate mRNA drug substance process scale up and manufacturing! This conference will showcase the pioneering work of 30+ global leaders across 3 days of immersive content sharing new […]

Co-create a commercial toolkit that enables suitable, scalable and sustainable growth.  With over 20 CGTs projected to be approved by 2025, it’s clear that there are huge commercial and medical opportunities for precision medicine. But despite this unprecedented growth, unstable infrastructure, lack of standardization and novel scientific nuance means that there is still no industry […]

Part of the 13th annual RNA Therapeutic series of events SMi’s 2nd Annual Conference Oligonucleotide Therapeutics and Delivery Conference 2022 Date: 21st – 22nd September 2022 Location: London, UK Website: www.oligonucleotide.co.uk/PharmaJournalist Advancements in extra-hepatic delivery of oligonucleotides The Oligonucleotide Therapeutics and Delivery conference reveals the latest in oligonucleotide discovery and delivery, with presentations on targeted […]

For decades, RAS has existed as an elusive therapeutic target, and drugging this high-value oncogene was deemed impossible. Despite this, the first-ever FDA-approved KRAS G12C inhibitor has demonstrated that RAS is, in fact, druggable and that drugging this protein unlocks a world of successful therapeutic interventions. The future looks bright for treating patients with cancers harboring the […]